You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Fortune reports that a Philadelphia-area hospital system is offering its employees free genetic testing.
Two recent publications suggest that DeepVariant's machine learning is far superior to traditional methods of variant calling, especially with hardware accelerators.
Othman Laraki, the CEO and co-founder of Color Genomics chats with Barron's Penta.
The company presented Color Data as a resource for variant classification scientists and hopes it will inspire industry peers to similarly share data.
Stat News reports that pharmacogenomics testing in psychiatry may be ahead of the science.
Researchers led by MD Anderson’s Karen Lu want to know the most efficient genetic counseling strategy as more people are getting screened for cancer risk genes.
CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.
Rainbow will offer Color's hereditary cancer and heart health genetic risk assessment tests to patients in Hong Kong.
The study aims to understand the willingness of individuals with a clinical diagnosis of familial hypercholesterolemia and their family members to undergo confirmatory genetic testing.
The firm will provide its genetic testing, counseling, and cascade screening to patients seen at a group of US health systems, focusing on CDC Tier 1 conditions.
A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.
Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.
The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.
In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.